KYYWF yields 0.10% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 5
Combined, KYYWF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KYYWF + JNJ for your $10,000?
Keywords Studios plc provides integrated outsourced creative and technical services to the video game industry. The company offers art creation services related to the production of graphical art assets for inclusion in the video game, including concept art creation, as well as 2D and 3D art asset production and animation. It also provides marketing services, which include game trailers, marketing art and materials, PR, and brand campaign services; and audio/voice-over services, including script translation, actor selection, and talent management through pre-production, audio direction, recording, and post-production, as well as offers music licensing or music soundtracks selling services. In addition, the company offers localization services related to translation and cultural adaptation of in-game text and audio scripts in various game platforms and genres; and localization testing services consisting of testing the linguistic correctness and cultural acceptability of computer games. Further, it provides functional testing services related to quality assurance services provided to game producers to ensure game functions. Additionally, the company provides player support services related to the live operations support, such as community management, player support, and associated services to producers of games, as well as software engineering services for developing video games. It serves game developers and publishers. The company operates in Canada, the United States, the United Kingdom, Italy, Russia, Japan, Poland, China, India, Ireland, the Philippines, Spain, France, Singapore, Australia, and internationally. Keywords Studios plc was founded in 1998 and is headquartered in Dublin, Ireland.
Full KYYWF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.